tiprankstipranks
Evaxion Biotech (NASDAQ:EVAX) Soars as First Patient Enrolled in Cancer Therapy Trial
Market News

Evaxion Biotech (NASDAQ:EVAX) Soars as First Patient Enrolled in Cancer Therapy Trial

Evaxion Biotech (NASDAQ:EVAX) is flying high today as the company’s personalized cancer therapy EVX-01 reached an important milestone.

EVAX has now enrolled the first patient in the global Phase 2b trial of EVX-01which is being developed for the treatment of melanoma.

The trial is evaluating the efficacy and safety of the therapy in adults with metastatic melanoma.

Read full Disclosure

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles